The FDA has approved Lipfendra, a once-daily oral PCSK9 inhibitor for adults with high LDL cholesterol. The pill offers an alternative to injections for patients who need further LDL reduction beyond ...
Hundreds of new medicines remain stuck without pricing approval, leaving patients waiting while companies see investments frozen ...
Travel medicine specialist Dr Richard Dawood explains what to pack, which vaccines you need and when it’s time to seek ...
The FDA has approved a first-of-its-kind pill that can drastically reduce cholesterol that's previously only been available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results